RHYTHM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $284.2M | $59.2M |
| FY2022 | — | $264.3M | $127.7M |
| FY2023 | $106.1M | $169.8M | $60.1M |
| FY2024 | $108.3M | $21.7M | $89.1M |
| FY2025 | $100.9M | $139.1M | $54.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $284.2M | $59.2M |
| FY2022 | — | $264.3M | $127.7M |
| FY2023 | $106.1M | $169.8M | $60.1M |
| FY2024 | $108.3M | $21.7M | $89.1M |
| FY2025 | $100.9M | $139.1M | $54.3M |